The short answer
Paracetamol is among the most heavily procured molecules in the world, and it is also one of the easiest to buy badly. The molecule is simple; the sourcing problem is not. A buyer needs a supplier who controls the active ingredient, runs the finished-dosage lines that shape it for the patient, and can hand over a complete registration file for the exact market being entered. Artemisine Medicines Technology manufactures 5,000 tons per year of paracetamol API (DML No. Jin20160069) and converts it in-house into 16 antipyretic and analgesic finished dosage forms — pediatric syrups, oral solutions, suspensions, granules, suppositories, tablets and injections — shipped with full documentation into more than 50 countries.
This guide sets out what to specify, what to verify and what to demand in writing before you sign a paracetamol supply agreement. It is written for procurement leads at pharmaceutical distributors, hospital groups, pharmacy chains and national procurement agencies.
Why pediatric antipyretics are a different procurement problem
Most buyers treat paracetamol as a single SKU. It is not. The commercial and regulatory problems sit in three places:
- The patient cannot always swallow. Fever in a vomiting child, a post-operative patient or an unconscious patient needs a route that is not oral. That means suppositories and injectables, not a smaller tablet.
- The concentration decides the arithmetic. Pediatric dosing is weight-based, so the mg/mL concentration of a liquid determines whether the label supports the dose your clinician intends.
- The file, not the drum, is the deliverable. A paracetamol product that cannot be registered cannot be sold, however good the batch certificate looks.
Specify the dosage form before you ask for a price
Before requesting a quotation, fix the presentation for each channel. The following are the reference presentations held in the Artemisine antipyretic and analgesic line, with the finished products available for evaluation.
| Presentation | Strength | Typical buyer use |
|---|---|---|
| Paracetamol syrup for children, 60 mL | 160 mg/5 mL | Pediatric OTC retail, private label |
| Paracetamol oral solution for children | 160 mg/5 mL, 237 mL | Pediatric retail, larger bottle economics |
| Paracetamol oral suspension | 160 mg/5 mL, 60 mL | Hospital and pharmacy dispensing |
| Paracetamol granules | 160 mg + vitamin C 50 mg + chlorphenaminum 1 mg | Pediatric sachet packs, cold formulations |
| Paracetamol suppository | 150 mg | Patients who cannot take oral medicines |
| Paracetamol tablets | 500 mg | Adult OTC, hospital formularies |
| Paracetamol effervescent tablets | 500 mg | Dysphagia, travel and soluble formats |
| Paracetamol injection | 500 mg/5 mL | Hospital intravenous use |
The Artemisine syrups category also carries lactulose solution, levocarnitine oral solution, ebastatine and vitamin formulations, so pediatric and adult liquid lines can be consolidated under one supply agreement rather than several.
Seven questions to put in the request for quotation
- Who actually makes the API, and where does control change hands? Ask whether the paracetamol API is made in-house or traded in. Artemisine runs 5,000 tons per year of paracetamol API into its own lines, with raw material incoming inspection, monograph identity, purity and assay verification, in-process monitoring and full finished-product testing.
- Which pharmacopoeial standard applies, and which documents travel with the goods? Specify the standard in writing. Artemisine releases this line to BP / enterprise standards and supports market access with COA, COPP, DMF and CTD-format dossiers, backed by HPLC and GC results and full export certificates.
- Is there stability and retention data behind the shelf life you are selling? Artemisine runs stability to ICH Q1A / WHO guidelines — long-term at 25 °C / 60 % RH and accelerated at 40 °C / 75 % RH — keeps at least one batch per product per year in the continuing stability program, and retains samples until one year beyond the labelled expiry date.
- Can the supplier build your presentation and packaging? Packing is customized per market requirement (bottle / blister / box), and Artemisine offers OEM and private-label work covering customized formulation, packaging and documentation for medicine and supplement projects.
- What capacity sits behind the quoted price? Ask for the numbers, not the adjectives. Published Artemisine capacity: 2 billion tablets per year, 1 billion capsules, 50 million sachets of granules and powders, 300 million ampoule injections and 100 million IV infusion bottles.
- Will your regulator and your customers accept the site? The workshops passed the China GMP on-site inspection in 2026, and the pharmaceutical quality system follows the WHO GMP framework (WHO TRS series). Cleanrooms run Grade A to D, with a Grade A filling zone on a Grade B background, and Water for Injection is produced by 3-stage reverse osmosis plus multi-effect distillation, stored and circulated above 70 °C. On-site and remote audits are welcome.
- How are deviations, changes and complaints handled once you are a customer? The documented quality system covers quality manual, SOPs, batch records and training records; deviations are investigated to root cause with CAPA tracked to closure; changes to materials, equipment, process or documents are risk-assessed and validated before implementation; every product gets an annual product quality review; and no batch ships without independent QA release.
What Artemisine can supply in this category
Beyond paracetamol, the same lines support the wider fever-and-pain portfolio, so a single agreement can cover the full category: ibuprofen oral suspension at 100 mg/5 mL as the common pediatric alternative to paracetamol, ibuprofen suppositories at 50 mg for non-oral routes, paracetamol 150 mg suppositories, and adult lines including paracetamol 500 mg tablets and paracetamol effervescent tablets at 500 mg. For hospital buyers the injectable route is covered by paracetamol injection 500 mg/5 mL, and pediatric sachet formats are available as paracetamol, vitamin C and chlorphenaminum granules. Every product in the line ships with COA, COPP, DMF and CTD dossiers for OTC registration, and the site has supplied syrups into more than 50 countries across Africa, Southeast Asia, Latin America and the Middle East, including ministry-of-health registration and international tenders.
A practical procurement checklist
- Fix presentation, strength, pack size and label language before requesting a price.
- Ask for a current batch COA alongside the quotation, not only a product brochure.
- Request the CTD-format dossier, DMF listing, COPP and stability summary in the same message as the RFQ.
- Get the release standard and the assay and impurity panel confirmed in writing.
- Ask for the GMP certificate, the 2026 inspection record and the water system validation summary — the Artemisine quality documentation page sets out what is available for regulatory submissions.
- Confirm MOQ, current stock and lead time against your named destination market and annual volume; Artemisine confirms these within 24 hours of receiving the request.
- Lock packaging and artwork, and check local labelling and import requirements with your authority before printing.
- Place a first order or run an audit before committing an annual volume.
Next step
Send the target market, the presentations you need and your expected annual volume, and the Artemisine export team will confirm availability, MOQ, lead time and the document package. Full company background, factory and qualification detail is on the Artemisine company profile; product specifications are listed in the syrups and suppositories categories. Start with an inquiry to the Artemisine export team and a documentation pack will be sent against your target market.
Frequently asked questions
What is the minimum order quantity for pediatric paracetamol syrup?
MOQ depends on the product, strength, packaging and destination market. Regular items are held in stock for fast delivery — send the target market and annual volume, and the Artemisine export team confirms current stock, MOQ and lead time within 24 hours.
Which documents can you provide for a paracetamol registration?
COA, COPP, DMF and CTD-format dossiers for every product in the line, supported by HPLC and GC results, GMP certificates, water system validation summaries and stability data under ICH Q1A / WHO guidelines. Legalisation support is provided where the destination authority requires it.
How is the stability of pediatric paracetamol liquids controlled?
Stability follows ICH Q1A and WHO guidelines, with long-term studies at 25 °C / 60 % RH and accelerated studies at 40 °C / 75 % RH in qualified chambers, at least one batch per product per year in the continuing stability program, and retention samples held in monitored storage until one year beyond the labelled expiry date — every batch traceable and retestable.
Source: dosing and clinical reference summarised from the WHO Model Formulary and WHO Model List of Essential Medicines, World Health Organization; manufacturing, capacity and quality facts from Artemisine GMP documentation. This guide is for buyer education only — clinical decisions must follow the locally approved product insert and national treatment guidelines.
Artemisine Medicines